An Extremophile Deep Sea Peptide to Combat Cystic Fibrosis Infections Caused by Pseudomonas aeruginosa and Staphylococcus aureus
Published:
05/12/2026
Boidin-Wichlacz, C.; Maresca, M.; Grandjean, T.; Grandé, A.; Huchez, O.; Jeannot, K.; Desmet, R.; Snella, B.; Vidal, N.; Genet, L.; et al.
Marine Drugs 2026, 24, 164.
Cystic fibrosis (CF)-associated lung infections caused by Pseudomonas aeruginosa (P. aeruginosa) and Staphylococcus aureus (S. aureus) remain difficult to treat due to multidrug resistance and the redox instability of the pulmonary environment, which can impair antibiotic efficacy.
